Research Article
APOE Genetic Polymorphism rs7412 T/T Genotype May Be a Risk Factor for Essential Hypertension among Hakka People in Southern China
Table 4
Clinical characteristics of subjects stratified by MTHFR rs1801133 genotypes and alleles.
| Clinical characteristics | C/C (n = 2,718) | C/T (n = 1,853) | T/T (n = 313) | values | C allele (C/C + C/T) (n = 4,571) | T allele (C/T + T/T) (n = 2,166) | values |
| Age, years | 66.81 ± 12.38 | 66.66 ± 12.31 | 65.81 ± 12.40 | 0.394 | 66.75 ± 12.35 | 66.54 ± 12.32 | 0.505 |
| Gender | Male, n(%) | 1753 (64.50) | 1193 (64.38) | 214 (68.37) | 0.377 | 2946 (64.45) | 1407 (64.96) | 0.703 | Female, n(%) | 965 (35.50) | 660 (35.62) | 99 (31.63) | | 1625 (35.55) | 759 (35.04) | | History of smoking, n(%) | 752 (27.67) | 520 (28.06) | 89 (28.43) | 0.933 | 1272 (27.83) | 609 (28.12) | 0.816 | History of alcoholism, n(%) | 170 (6.25) | 119 (6.42) | 20 (6.39) | 0.977 | 289 (6.32) | 139 (6.42) | 0.915 | SBP, mmHg | 141.80 ± 27.63 | 141.73 ± 26.68 | 141.99 ± 23.52 | 0.987 | 141.77 ± 27.25 | 141.77 ± 26.25 | 0.999 | DBP, mmHg | 82.23 ± 15.69 | 82.83 ± 15.73 | 83.67 ± 14.62 | 0.190 | 82.48 ± 15.71 | 82.95 ± 15.57 | 0.243 | Hcy, μmol/L | 15.85 ± 6.59 | 16.76 ± 8.18 | 21.74 ± 13.71 | <0.001 | 16.22 ± 7.29 | 17.48 ± 9.35 | <0.001 | TG, mmol/L | 1.77 ± 1.85 | 1.76 ± 1.58 | 1.73 ± 1.51 | 0.904 | 1.77 ± 1.74 | 1.76 ± 1.57 | 0.781 | TC, mmol/L | 4.91 ± 1.44 | 4.84 ± 1.38 | 4.89 ± 1.30 | 0.301 | 4.88 ± 1.42 | 4.85 ± 1.37 | 0.366 | HDL-C, mmol/L | 1.27 ± 0.40 | 1.26 ± 0.39 | 1.26 ± 0.35 | 0.595 | 1.27 ± 0.40 | 1.26 ± 0.38 | 0.518 | LDL-C, mmol/L | 2.74 ± 0.99 | 2.71 ± 0.98 | 2.74 ± 0.95 | 0.536 | 2.72 ± 0.99 | 2.71 ± 0.97 | 0.609 | Apo-A1, g/L | 1.11 ± 0.34 | 1.10 ± 0.33 | 1.11 ± 0.29 | 0.719 | 1.10 ± 0.33 | 1.10 ± 0.33 | 0.819 | Apo-B, g/L | 0.85 ± 0.29 | 0.84 ± 0.29 | 0.86 ± 0.29 | 0.678 | 0.85 ± 0.29 | 0.85 ± 0.29 | 0.904 |
|
|